Form 4 · Filed May 19, 2026, 09:20 PM UTC
PTCT/PTC THERAPEUTICS, INC.
Boulding Mark Elliott — EXEC. VP AND CLO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 15, 2026 | M | other | 2,812 | $26 | $72,240 | 108,024 |
| May 15, 2026 | S | sell | 2,356 | $72 | $169,820 | 105,668 |
| May 15, 2026 | S | sell | 456 | $73 | $33,138 | 105,212 |
| May 15, 2026 | M | other | 2,812 | — | — | 19,689 |
Source: SEC EDGAR raw filing ↗ · Accession 0001578852-26-000016